GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
MEDIVATION INC (MDVN) [hlAlert]

Rating:
Buy MDVN
up 781.47 %

MEDIVATION INC (MDVN) rated Buy

Posted on: Wednesday,  Oct 31, 2007  11:25 AM ET by Pacific Growth Equities

Pacific Growth Equities rated Buy MEDIVATION INC (NASDAQ: MDVN) on 10/31/2007, when the stock price was $10.45. Since
then, MEDIVATION INC has gained 781.47% as of 01/27/2016's recent price of $92.07.
If you would have followed this Pacific Growth Equities's recommendation on MDVN, you would have gained 781.47% of your investment in 3010 days.

Medivation, Inc. is a biopharmaceutical company with small molecule drugs in clinical development to treat three medical needs: Alzheimer?s disease, Huntington?s disease and castration-resistant prostate cancer. The Company has formed separate subsidiaries to hold the product candidates it is developing. The Company?s subsidiary Medivation Neurology, Inc. holds its Dimebon technology, and its subsidiary Medivation Prostate Therapeutics, Inc. holds its MDV300 series technology.

The Pacific Growth Equities research department strives to stay ahead of breaking news in some of the fastest moving and most complicated industries on Wall Street. Our research names are affected not only by economic swings but also by specific government regulations, new legislation, and often public opinion. Staying on top of every nuance allows us—and our clients—to lead and not follow. We take pride in providing incremental, value-added insights to the global institutional investment community. Our analysts are experienced in both industry and Wall Street, and are empowered to make the tough calls. Research insights are delivered quickly to the appropriate decision-makers so that important investment opportunities will not be lost. Any research analyst can call an impromptu meeting when news is breaking, to keep the sales force and management abreast of events that could impact the market both from a macro point of view and from one that is stock-specific.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/31/2007 11:25 AM Buy
None
10.45
as of 8/27/2015
1 Week down  -10.35 %
1 Month down  -20.67 %
3 Months down  -25.37 %
1 YTD up  44.26 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy